Q1 2026 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue | -2.4% | Revenue fell from $1,529.14M in Q1 2025 to $1,493.4M in Q1 2026, driven by lower product sales volumes stemming from soft discretionary spending—an effect consistent with prior period influences. |
Products segment revenue | -3% | The Products segment declined from $1,279.73M to $1,241.9M, primarily due to reduced sales in supplies and companion animal categories, reflecting weakened consumer demand similar to earlier periods. |
Services & Other revenue | Slight increase | Services & Other revenue edged up from $249.41M to $251.5M, benefiting from ongoing strategic investments in customer retention and an expanding, mature veterinary hospital footprint that helped offset declines in other segments. |
Cash and Cash Equivalents | +48.5% | Cash and cash equivalents surged from $89,717K to $133,343K, reflecting improved liquidity due to stronger operating cash flows and reduced debt repayments compared to previous periods. |
Total Assets | -2.6% | Total assets decreased to $5,121,136K as lower capital expenditures and depreciation of fixed assets continued trends seen in earlier periods, indicating a contraction in asset base. |
Total Current Liabilities | Modest increase | Current liabilities rose modestly to $1,083,477K, likely due to a slight increase in accrued obligations and adjustments in short-term debt components, mirroring earlier period trends. |
Stockholders’ Equity | -4.3% | Stockholders’ equity declined to $1,107,330K, primarily due to net losses and cumulative comprehensive losses, underscoring pressures from operational challenges that persisted from previous periods. |